New report provides Rheumatoid Arthritis market insight
Date Published:
Q1 Price:
$6,000 Source:
Med Predict The key issue for MedPredict’s Thought
Leader Panel was switching: How long should anti-TNF therapy be tried? What comes next? And what would challenge anti-TNF therapy for
1st-line usage? Also discussed: developing
commercial issues, new mechanisms, unmet needs. Learn More.
More Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight
- The Fastest Growing Biotechnology Companies
- Addressing Key Challenges in Drug Safety (Strategic Focus)
- Pharmaceuticals: Global Industry Guide
- The Future of Targeted Therapeutics
- Impact of Pharmacogenomics on Public Healthcare Policy